Marlon Daito

Recommended Articles

• What is Keratoconus?

  Keratoconus is a non-inflammatory disorder of the eye where the cornea bulges outward like a cone. Thinning and bulging of cornea may result in blurring of vision and make the eye more sensitive to light. This disorder is seen in both the eyes and is common in people from 10-years-old to...

• A Guide to Surviving the First Year of Nursing

  There are really no ways to describe all those feelings that a newly graduated nurse can feel.  From the pride of successfully reaching a goal to the excitement of landing that first nursing job and finally, the nervous jitters that come along with treating a patient for the first time as a...

• Somnoware Launches New Software for Sleep Apnea and COPD

  Sleep apnea and COPD usually come together as overlapping illnesses. Sleep apnea is also known as Obstructive Sleep Apnea or OSA and Chronic obstructive pulmonary disease is known as COPD for short. These are two very common pulmonary diseases that are individually attained but most of the time...

• Stretching Before Running Does Not Prevent or Cause Injury

  According to a new and interesting study stretching before running may not prevent or cause injury but switching the routine increases the risk of injury considerably. The results of the study presented at the annual meeting of the American Academy of Orthopaedic Surgeons provided a surprise twist...

• New Crohn's and Colitis Treatment May Combine Antifungals and Probiotics

  A recent review, published in the Digestive and Liver Disease journal, proposes that new types of IBD treatment can come from combining antifungals with probiotics. Probiotics are live microorganisms that are believed to offer health-related benefits when consumed and bacteria can contain probiotic...

• Common Multiple Sclerosis Treatments: An Overview

  A debilitating disease that was once the face of a crushing and “hopeless” diagnosis has evolved from having one effective treatment to multiple effective treatments. Longtime sufferers who didn’t respond to one medication now have options to try others, to participate in a clinical trial or...